Sakabe, Isamu
Hu, Rong
Jin, Lu
Clarke, Robert
Kasid, Usha N.
Funding for this research was provided by:
National Institutes of Health (CA68322)
National Institutes of Health (CA184902, CA149147)
Article History
Received: 6 June 2015
Accepted: 7 August 2015
First Online: 13 August 2015
Compliance with ethical standards
:
: TMEM33 (alias SHINC-3) is a Georgetown University patented technology, “Gene SHINC-3 and Diagnostic and Therapeutic Uses Thereof,” US Patent # 7244565. IS and UK are co-inventors of this technology. RH, LJ and RC declare that they have no conflict of interest.
: The authors declare that all experiments reported in this manuscript were performed in compliance with all current laws and regulations of the United States of America.